RESPIRATORY

Pharmacotherapy of IPF Using Antifibrotic Compounds

Oct 1, 2016 by in RESPIRATORY Comments Off on Pharmacotherapy of IPF Using Antifibrotic Compounds

Fig. 9.1 Pathogenesis of IPF and the mechanism of action of antifibrotic agents 9.3 Pirfenidone 9.3.1 Mechanism of Action Animal studies have shown that pirfenidone suppresses accumulation of inflammatory cells…

read more

Differential Diagnosis of IPF

Oct 1, 2016 by in RESPIRATORY Comments Off on Differential Diagnosis of IPF

1. IPF is defined as a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause, occurring primarily in older adults, limited to the lungs, and associated with the…

read more

Pathogenesis of IPF

Oct 1, 2016 by in RESPIRATORY Comments Off on Pathogenesis of IPF

Fig. 4.1 Schematic drawing of the proposed molecular pathogenesis of IPF. AEC, alveolar epithelial cell; EMT, epithelial-mesenchymal transition; ECM, extracellular matrix 4.2 Epithelial Injury and Genetic Background Studies of the…

read more

Epidemiology and Risk Factors of IPF

Oct 1, 2016 by in RESPIRATORY Comments Off on Epidemiology and Risk Factors of IPF

Fig. 2.1 Alveolar epithelial cells are thought to be the initial lesion of lung injury caused by environmental factors, such as smoking, inhalational agents, drugs, oxygen radicals, toxins, and viruses,…

read more

The Evaluation of the Upper and Lower Airways in Infants and Children: Principles and Pearls from Four Decades in the Trenches

Oct 1, 2016 by in RESPIRATORY Comments Off on The Evaluation of the Upper and Lower Airways in Infants and Children: Principles and Pearls from Four Decades in the Trenches

Fig. 1.1 Flexible and rigid instruments approach the larynx from very different perspectives. A rigid instrument necessarily elevates the hyoid and tongue base, lifting and distorting the larynx, while at…

read more
Get Clinical Tree app for offline access